Prediction Case File
YouTubeEvaluation Complete

Friends! In this video, I'm going to talk about ASML stock, ADOBE stock & OTIS stock

3 extracted signals · 3 resolved · 0 still active

The Patient Investor profile imageThe Patient Investor19 Aug 2025, 22:23 UTC
Video preview for Friends! In this video, I'm going to talk about ASML stock, ADOBE stock & OTIS stock
Signals
3
Eligible signals in this source
Open
0
Still being tracked
Resolved
3
Evaluable outcomes
Successful
1
Canonical correct result
Failed
2
Canonical failed result
Resolved success
33.33%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video discusses three stock picks the presenter likes, even though the overall S&P 500 market is trading at high valuations. The first stock analyzed is ASML, currently priced at $742.16; the presenter believes its growth hasn't fully reflected in the market, considering it the toll bridge to innovation. He notes ASML's significant market share in semiconductor lithography, coupled with double-digit revenue growth in its installed base management segment. The risk he assigns is the dependence on China. Secondly, the presenter considers Adobe at a PE of 16 attractive, and suggests it has solid fundamentals, despite bad market sentiment; as it is a software business with a high percentage of recurring revenues and a dividend. Finally, OTIS at $87.43 trades below its average earnings and has strong service businesses with steady cashflows; the downside is China as well.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  4. Market predictions extracted

    3 eligible signals linked to this case.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

The Patient Investor

Tracked signals
292
Historical success
32.9%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.